Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates

Class:IdLiteratureReference:8852667
_displayNameMorphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates
_timestamp2016-01-19 21:16:26
author[Person:8852662] Brown, Robert E
[Person:8852663] Tan, Dongfeng
[Person:2530522] Taylor, Jeffrey S
[Person:8852669] Miller, Michal
[Person:8852671] Prichard, Jeffrey W
[Person:8852665] Kott, Marylee M
created[InstanceEdit:8852672] Orlic-Milacic, Marija, 2016-01-19
journalAnn. Clin. Lab. Sci.
pages141-7
pubMedIdentifier17522369
titleMorphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates
volume37
year2007
(literatureReference)[Summation:8852659] Expression of the NBPF1 mRNA is repressed in response to TNF...
[Change default viewing format]
No pathways have been reviewed or authored by Morphoproteomic confirmation of constitutively activated mTOR, ERK, and NF-kappaB pathways in high risk neuro-blastoma, with cell cycle and protein analyte correlates (8852667)